ISRAEL’S MEDICAL ACHIEVEMENTS
Israeli breakthrough in cancer treatment. This could be it. Teams of Israeli scientists from Tel Aviv University and Sheba and Hadassah Medical centers working together have triggered cell death in tumors. Derivatives of the compound Phenanthridine caused cancer cells to self-destruct in the most resistant and incurable cancers such as pancreatic. Watch this space! http://www.jewishpress.com/news/israel/israeli-scientists-find-mechanism-that-causes-cancer-cells-to-self-destruct/2017/03/27/ http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=15343
Prolonging the lives of cancer patients. Professor Dror Harats, CEO of VBL Therapeutics on ILTV News described the Phase 2 results of VB-111. The treatment (now in Phase 3 trials) doubles survival time for brain tumor patients and ovarian cancer patients. It works for most solid tumor cancers. (Reported here previously)
https://www.youtube.com/embed/4HeISdYw7d8?rel=0
Israeli doctor leads world congress on miscarriage. (TY Eli) Professor Asher Bashiri of Israel’s Soroka University Medical Center led the 2017 World Congress on Recurrent Pregnancy Loss, held in Cannes, France. Doctors representing over 50 countries attended. http://www.ynetnews.com/articles/0,7340,L-4911295,00.html
PolyPid joins US infectious disease program. I reported previously (twice) about Israel’s PolyPid slow-release antibiotic bone implants. PolyPid has just been accepted into the US FDA Qualified Infectious Disease Program – a new FDA status for innovative products in the treatment of bacteria resistant to antibiotics.
http://www.globes.co.il/en/article-fda-fast-tracks-israeli-co-polypid-1001180587
Incubating nine medical startups. Israel’s Teva and Philips Healthcare selected 9 from 750 startups for their Sanara joint Israeli medical incubator. They include MeWay (nebulizer) Myhomedoc (smartphone checkup and diagnosis), BReathme (asthma management), Purecare (gum treatment), Lensfree (lowers CT radiation), Lifegraph (migraine prevention), Lidus (blood vessel suturing) and SpirCare (lung capacity measurement).
http://www.globes.co.il/en/article-teva-philips-israel-incubator-selects-9-projects-1001180561
Israeli takeover of UK cancer biotech. Israel’s BiolineRx is buying UK’s Agalimmune,for $6 million. The private UK-based company has developed an innovative, anti-cancer immunotherapy platform. treatment that not only kills the tumor cells at the site of injection, but also brings about a durable, follow-on, anti-metastatic immune response. http://www.globes.co.il/en/article-biolinerx-buys-uk-co-1001182333